Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
BMC Musculoskeletal Disorders|September 14, 2024
Osseointegration potential of boron-coated titanium alloy pedicle screw in rabbit spine modelHidir Ozer, Mehdi Hekimoğlu, Ibrahim Kulac, et al.Endocrine Pathology|January 23, 2025
Deep Learning Enabled Scoring of Pancreatic Neuroendocrine Tumors Based on Cancer Infiltration PatternsSoner Koc, Ozgur Can Eren, Rohat Esmer, et al.Genes, Chromosomes & Cancer|August 12, 2024
A Novel JAK2 Fusion in T-Cell Prolymphocytic LeukemiaOzgur Can Eren, Robert Stuver, Ting Zhou, et al.BMC Pregnancy and Childbirth|June 14, 2024
Dysbiosis in pregnant mice induced by transfer of human vaginal microbiota followed by reversal of pathological changes in the uterus and placenta via progesterone treatmentGulin Ozcan, Zeynep Gülçe Tanyolaç Talay, Erxiati Paerhati, et al.Haematologica|November 27, 2025
Cumulative incidence and factors associated with subsequent myeloid neoplasms in patients with nodal T-follicular helper cell lymphomasKai Shiang Lin, Mingfei Yan, Nivetha Ganesan, et al.Breast Care (Basel, Switzerland)|October 30, 2023
Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2- Breast Cancer PatientsAdela-Luciana Oprea, Bahadir Gulluoglu, Yusuf Emre Aytin, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 15, 2024
Characterizing Nodal Gamma-Delta T-Cell Lymphoma: Clinicopathological and Molecular InsightsMing Liang Oon, Jing Quan Lim, Jan Bosch-Schips, et al.Endocrine Pathology|October 11, 2025
Intratumoral Heterogeneity of Ki67 Index and Its Impact on the Diagnosis and Prognostication of Pancreatic Neuroendocrine Tumors: Hot-Spot Count Differs Significantly from Random-Area CountOzgur Can Eren, Nobuyuki Ohike, Deniz Tuncel, et al.Annals of Surgical Oncology|July 2, 2024
Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management ProtocolsOzgur Can Eren, Pelin Bagci, Serdar Balci, et al.Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric studyMingfei Yan, Sameer A Parikh, Michelly K Sampaio De Melo, et al.Pageof 3